These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18157123)

  • 1. Site selectivity of platinum anticancer therapeutics.
    Wu B; Dröge P; Davey CA
    Nat Chem Biol; 2008 Feb; 4(2):110-2. PubMed ID: 18157123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum drug adduct formation in the nucleosome core alters nucleosome mobility but not positioning.
    Wu B; Davey CA
    Chem Biol; 2008 Oct; 15(10):1023-8. PubMed ID: 18940663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide excision repair from site-specifically platinum-modified nucleosomes.
    Wang D; Hara R; Singh G; Sancar A; Lippard SJ
    Biochemistry; 2003 Jun; 42(22):6747-53. PubMed ID: 12779329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 a resolution.
    Davey CA; Sargent DF; Luger K; Maeder AW; Richmond TJ
    J Mol Biol; 2002 Jun; 319(5):1097-113. PubMed ID: 12079350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal tail domains of core histones in nucleosome block the access of anticancer drugs, mithramycin and daunomycin, to the nucleosomal DNA.
    Mir MA; Das S; Dasgupta D
    Biophys Chem; 2004 Apr; 109(1):121-35. PubMed ID: 15059665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA nanomechanics in the nucleosome.
    Becker NB; Everaers R
    Structure; 2009 Apr; 17(4):579-89. PubMed ID: 19368891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteins that bind to and mediate the biological activity of platinum anticancer drug-DNA adducts.
    Whitehead JP; Lippard SJ
    Met Ions Biol Syst; 1996; 32():687-726. PubMed ID: 8640535
    [No Abstract]   [Full Text] [Related]  

  • 8. A K52Q substitution in the globular domain of histone H1t modulates its nucleosome binding properties.
    Ramesh S; Bharath MM; Chandra NR; Rao MR
    FEBS Lett; 2006 Oct; 580(25):5999-6006. PubMed ID: 17052712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and unique interactions with DNA of a cationic trans-platinum complex with the nonplanar bicyclic piperidinopiperidine ligand.
    Najajreh Y; Prilutski D; Ardeli-Tzaraf Y; Perez JM; Khazanov E; Barenholz Y; Kasparkova J; Brabec V; Gibson D
    Angew Chem Int Ed Engl; 2005 May; 44(19):2885-7. PubMed ID: 15822135
    [No Abstract]   [Full Text] [Related]  

  • 10. A ruthenium antimetastasis agent forms specific histone protein adducts in the nucleosome core.
    Wu B; Ong MS; Groessl M; Adhireksan Z; Hartinger CG; Dyson PJ; Davey CA
    Chemistry; 2011 Mar; 17(13):3562-6. PubMed ID: 21344528
    [No Abstract]   [Full Text] [Related]  

  • 11. Global analysis of functional surfaces of core histones with comprehensive point mutants.
    Matsubara K; Sano N; Umehara T; Horikoshi M
    Genes Cells; 2007 Jan; 12(1):13-33. PubMed ID: 17212652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative affinities of DNA sequences for the histone octamer depend strongly upon both the temperature and octamer concentration.
    Wu C; Travers A
    Biochemistry; 2005 Nov; 44(43):14329-34. PubMed ID: 16245949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin structure. The nucleosome core all wrapped up.
    Rhodes D
    Nature; 1997 Sep; 389(6648):231, 233. PubMed ID: 9305832
    [No Abstract]   [Full Text] [Related]  

  • 14. Consequences of cisplatin binding on nucleosome structure and dynamics.
    Todd RC; Lippard SJ
    Chem Biol; 2010 Dec; 17(12):1334-43. PubMed ID: 21168769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin damage overrides the predefined rotational setting of positioned nucleosomes.
    Ober M; Lippard SJ
    J Am Chem Soc; 2007 May; 129(19):6278-86. PubMed ID: 17432860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal-intercalator-mediated self-association and one-dimensional aggregation in the structure of the excised major DNA adduct of a platinum-acridine agent.
    Baruah H; Day CS; Wright MW; Bierbach U
    J Am Chem Soc; 2004 Apr; 126(14):4492-3. PubMed ID: 15070347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaction of Histone H1 with trans-Platinum Complexes and the Effect on DNA Platination.
    Cheng L; Li C; Yuan S; Shi H; Zhao L; Zhang L; Arnesano F; Natile G; Liu Y
    Inorg Chem; 2019 May; 58(9):6485-6494. PubMed ID: 31021622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific DNA structural attributes modulate platinum anticancer drug site selection and cross-link generation.
    Wu B; Davey GE; Nazarov AA; Dyson PJ; Davey CA
    Nucleic Acids Res; 2011 Oct; 39(18):8200-12. PubMed ID: 21724603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum anticancer drug damage enforces a particular rotational setting of DNA in nucleosomes.
    Danford AJ; Wang D; Wang Q; Tullius TD; Lippard SJ
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12311-6. PubMed ID: 16116097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origins of the distortions in the base pair step adjacent to platinum anticancer drug-DNA adducts. Fundamental NMR solution studies utilizing right-handed cross-link models having 5'- and 3'-flanking residues.
    Saad JS; Natile G; Marzilli LG
    J Am Chem Soc; 2009 Sep; 131(34):12314-24. PubMed ID: 19655752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.